Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 8
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Horasanlı, Bahriye Ataç, F. Belgin Çöven, İlker Karakurum Goksel, Basak and Benli, Sibel 2013. Angiotensin I-Converting Enzyme Gene (I/D) Polymorphism in Patients With Migraine. Headache: The Journal of Head and Face Pain, Vol. 53, Issue. 1, p. 161.

    Wernovsky, Gil 2012. Avery's Diseases of the Newborn.

    Andrew Kofke, W. 2010. Cottrell and Young's Neuroanesthesia.

    Ataç, Fatma Belgin İnce, Deniz Anuk Verdi, Hasibe Gökmen, Zeynel Yazici, Ayse Canan Gülcan, Hande Tarcan, Aylin Taneri, Ayse Sezgin, Ezgi and Özbek, Namık 2010. Lack of Association BetweenFXIII-Val34Leu,FVII-323 del/ins, and Transforming Growth Factor β1 (915G/T) Gene Polymorphisms and Bronchopulmonary Dysplasia: A Single-Center Study. DNA and Cell Biology, Vol. 29, Issue. 1, p. 13.

    Ozbek, Namik Alioglu, Bulent Avci, Zekai Malbora, Baris Onay, Ozge Ozyurek, Emel and Atac, Fatma Belgin 2009. INCIDENCE OF AND RISK FACTORS FOR CHILDHOOD THROMBOSIS: A Single-Center Experience in Ankara, Turkey. Pediatric Hematology and Oncology, Vol. 26, Issue. 1, p. 11.

    Koestenberger, Martin Cvirn, Gerhard Nagel, Bert Rosenkranz, Andrea Leschnik, Bettina Gamillscheg, Andreas Beitzke, Albrecht and Muntean, Wolfgang 2008. Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease. Thrombosis Research, Vol. 122, Issue. 1, p. 13.

    Rasmussen-Torvik, Laura J. Cushman, Mary Tsai, Michael Y. Zhang, Yan Heckbert, Susan R. Rosamond, Wayne D. and Folsom, Aaron R. 2007. The association of α-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thrombosis Research, Vol. 121, Issue. 1, p. 1.

    Serin, Ender Güçlü, Mustafa Ataç, F Belgin Verdi, Hasibe Kayaselçuk, Fazilet Özer, Birol Bilezikçi, Banu and Yılmaz, Uğur 2007. Methylenetetrahydrofolate Reductase C677T Mutation and Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences, Vol. 52, Issue. 5, p. 1183.


Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery

  • Namık Özbek (a1), F. Belgin Ataç (a2), Selman V. Yıldırim (a1), Hasibe Verdi (a2), Canan Yazıcı (a3), Başak T. Yılmaz (a1) and N. Kürşat Tokel (a1)
  • DOI:
  • Published online: 01 April 2005

In this study, we investigated some of the prothrombothic mutations and polymorphisms in 15 children with congenital cardiac malformations who developed severe thrombosis in the perioperative period following surgical repair. The mutations and polymorphisms included in the study were Factor V Leiden, prothrombin G20210A, methylentetrahydrofolate reductase C677T, endothelial nitric oxide synthase intron 4 VNTR, alpha-fibrinogen Thr312Ala, Factor XIII Val34Leu, and insertion or deletion of angiotensin 1 converting enzyme. Compared to the healthy Turkish subjects, our patients had a similar rate of mutation of Factor V Leiden, Factor XIII Val34Leu, and endothelial nitric oxide synthase a/b polymorphisms, but higher frequency of the prothrombotic angiotensin 1 converting enzyme deletion/deletion genotype, and lower frequency of the antithrombotic alpha fibrinogen Thr/Thr genotype. None of the patients exhibited mutations involving prothrombin G20210A or methylentetrahydrofolate reductase C677T. The results of our study suggest that, in addition to prothrombotic mutations such as Factor V Leiden, single-nucleotide polymorphisms should be considered in all children with congenital cardiac malformations who develop thrombosis.

Malformations of the heart are the most common of all serious lesions that are present at birth, with an incidence of 4 to 8 cases per 1,000 live births.1 If needed, corrective surgery is usually the optimal treatment for these anomalies, but perioperative morbidity and mortality still remain high due to several factors. Arterial or venous thrombosis, or both varieties of thrombosis, is among these factors. Prior to surgery, the most frequent time at which these children develop thrombosis is during cardiac catheterization. Postoperative thrombosis in this group of patients is a more complex disorder, which can affect both small and large vessels, and is associated with a high morbidity and mortality.

Recent studies indicate that both point mutations and single-nucleotide polymorphisms of genes that encode proteins involved in the coagulative and anticoagulative cascades are important risk factors for development of thrombosis. Patients with these risk factors are most likely to develop thrombosis when triggering elements, such as placement of catheters, prolonged immobilization, or surgery, are also present. In this study, we investigated some of the above-mentioned mutations and polymorphisms in children who developed thrombosis in the perioperative period after correction of congenital cardiac malformations.

Corresponding author
Correspondence to: Namık Özbek MD, Başkent Üniversitesi Pediatri Bölümü, 6. Cadde, No: 72/3, 06490 Bahçelievler, Ankara, Turkey. Tel: +90 312 2130776/2234936; Fax: +90 312 2157597; E-mail:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Cardiology in the Young
  • ISSN: 1047-9511
  • EISSN: 1467-1107
  • URL: /core/journals/cardiology-in-the-young
Please enter your name
Please enter a valid email address
Who would you like to send this to? *